These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8584396)

  • 1. The relationship between pertussis vaccine and central nervous system sequelae: continuing assessment. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1996 Feb; 97(2):279-81. PubMed ID: 8584396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perverse reactions to pertussis vaccine by government medical agencies.
    Sepkowitz S
    J Okla State Med Assoc; 1996 Apr; 89(4):135-8. PubMed ID: 8776165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Academy of Pediatrics Committee on Infectious Diseases: The relationship between pertussis vaccine and brain damage: reassessment.
    Pediatrics; 1991 Aug; 88(2):397-400. PubMed ID: 1861949
    [No Abstract]   [Full Text] [Related]  

  • 4. Diphtheria-tetanus-pertussis vaccine and serious neurologic illness: an updated review of the epidemiologic evidence.
    Wentz KR; Marcuse EK
    Pediatrics; 1991 Mar; 87(3):287-97. PubMed ID: 2000268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of pertussis immunization to the onset of epilepsy, febrile convulsions and central nervous system infections: a retrospective epidemiologic study.
    Jacobson V; Nielsen C; Buch D; Shields WD; Christenson P; Zachau-Christiansen B; Cherry JD
    Tokai J Exp Clin Med; 1988; 13 Suppl():137-42. PubMed ID: 3273613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study.
    Ray P; Hayward J; Michelson D; Lewis E; Schwalbe J; Black S; Shinefield H; Marcy M; Huff K; Ward J; Mullooly J; Chen R; Davis R;
    Pediatr Infect Dis J; 2006 Sep; 25(9):768-73. PubMed ID: 16940831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines.
    Geier DA; Geier MR
    Brain Dev; 2004 Aug; 26(5):296-300. PubMed ID: 15165669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of pertussis vaccine.
    Thomson KD
    N Z Med J; 1996 Mar; 109(1017):84. PubMed ID: 8606833
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of adverse effects following immunization with vaccine containing whole-cell vs. acellular pertussis components.
    Zieliński A; Rosińska M
    Przegl Epidemiol; 2008; 62(3):589-96. PubMed ID: 19108523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis vaccine.
    Shaw EB
    Pediatr Infect Dis; 1983; 2(3):264-5. PubMed ID: 6866793
    [No Abstract]   [Full Text] [Related]  

  • 11. Disputed claims for pertussis vaccine injuries under the National Vaccine Injury Compensation Program.
    Ridgway D
    J Investig Med; 1998 Apr; 46(4):168-74. PubMed ID: 9635377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students.
    Khan FN; Lin M; Hinkle CJ; Franklin P; Luther R; Woodruff F; Henson K; Lukenbill M; Gutierrez M; Zhu BP
    Pediatr Infect Dis J; 2006 Dec; 25(12):1132-6. PubMed ID: 17133158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands.
    David S; Vermeer-de Bondt PE; van der Maas NA
    Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurologic manifestations following pertussis vaccination].
    Aicardi J; Chevrie JJ
    Arch Fr Pediatr; 1975 Apr; 32(4):309-17. PubMed ID: 240337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis vaccination and epilepsy--an erratic history, new research and the mismatch between science and social policy.
    Shorvon S; Berg A
    Epilepsia; 2008 Feb; 49(2):219-25. PubMed ID: 18093146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis immunization and the central nervous system. Ad Hoc Committee for the Child Neurology Society Consensus Statement on Pertussis Immunization and the Central Nervous System.
    Ann Neurol; 1991 Apr; 29(4):458-60. PubMed ID: 1929219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
    Liese JG; Stojanov S; Belohradsky BH
    Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.